top of page
Sanofi Secures Approval for Beyfortus in India to Shield Infants and Children from RSV | iPharmaCenter
Sanofi India announced the receipt of marketing authorization for Beyfortus (nirsevimab) from the Central Drugs Standard Control...
Indian Pharma News | 2024 | iPharmaCenter
May 21, 2024 Glenmark and BeiGene Collaborate to Market and Distribute Tislelizumab and Zanubrutinib in India Key Points: Tislelizumab:...
India Drug Approvals | 2024 | CDSCO | News | Updates | Media | iPharmaCenter
19th January, 2024 Tirzepatide Recommended alongside dietary adjustments and physical activity to enhance blood sugar management in...
India | Drug Approvals | Pharma News | 2024 | iPharmaCenter
January 03, 2024 AstraZeneca India Unveils Trastuzumab Deruxtecan for HER2-Positive Metastatic Cases AstraZeneca India has officially...
India new drug approvals | India Pharma | 2023 | CDSCO | Ministry of health news | iPharmaCenter
September 30, 2023 AstraZeneca received approval from CDSCO for palivizumab to prevent RSV infection. AstraZeneca approved palivizumab, a...
India | Healthcare News | Abbott to upgrade 75 PHCs | iPharmaCenter
September 26, 2023 Cipla initiated drone services to deliver medicines to difficult-to-reach terrains. Cipla Limited has unveiled an...
Department of Pharmaceuticals report emphasize on need of academia to meet industry's requirement
A study was conducted by the Department of Pharmaceuticals in India to assess the skills required for the Indian pharmaceutical industry....
bottom of page